跳至主要内容
临床试验/NCT02708628
NCT02708628已完成不适用

The Efficacy of Prophylactic Use of Extract of Allium Cepae, Allantoin and Heparin in Patients With Proven Scar Development After Excision of Previous Scar

Suleymaniye Birth And Women's Health Education And Research Hospital1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2015年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
120
试验地点
1
主要终点
POSAS observer score change will be assessed by POSAS observer scale (The Patient and Observer Scar Assessment Scale v2.0) just prior to second c-section and at 6,12 and 24 weeks following the c-section.

研究概览

简要总结

To investigate the efficacy of prophylactic use of a topical gel containing extract of allium cepae, allantoin and heparin after surgical removal of the primary cesarean scar in the second cesarean section.

详细描述

120 patients who are admitted for the second cesarean delivery, not taking prophylactic medication after the first cesarean section, whose scar development and measurements are taken will be included in the study. First caesarean section scars will be removed surgically for all patients. 60 out of 120 patients (treatment group) will use prophylactic topical scar gel 2 times in a day, and remaining 60 patients (control group )won't use. The efficacy of the drug will be evaluated by taking strict measurements of the incision and POSAS (The Patient and Observer Scar Assessment Scale) and Vancouver Scales at 6.12 and 24 weeks.

Steps;

  1. Observation of the primary cesarean scar by taking scar measurements and using Vancouver and POSAS scales.
  2. Surgical removal of the primary cesarean scar in the second cesarean section.
  3. 24 weeks topical application of gel containing extract of allium cepae, allantoin and heparin(only treatment group).
  4. Observation of the skin incision at 6,12 and 24 weeks by taking scar measurements with using Vancouver and POSAS scales.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients who are admitted for the second cesarean delivery
  • Not to use topical scar gel after the first c-section

排除标准

  • chronic illness, immunosuppressive therapy or smoking
  • development of wound infection during the second c- section
  • allergies and hypersensitivities to components of the gel

研究组 & 干预措施

Patients using contractubex

Active Comparator

Scar excision will be performed in second c-section for 60 patients and these patients will use prophylactic topical scar gel containing extract of allium cepae, allantoin and heparin two times in a day.

干预措施: extract of allium cepae, allantoin and heparin (Drug)

Patients using contractubex

Active Comparator

Scar excision will be performed in second c-section for 60 patients and these patients will use prophylactic topical scar gel containing extract of allium cepae, allantoin and heparin two times in a day.

干预措施: Scar excision (Procedure)

Patients not using contractubex

Active Comparator

Scar excision will be performed in second c-section for 60 patients and these patients will not use prophylactic topical scar gel containing extract of allium cepae, allantoin and heparin.

干预措施: Scar excision (Procedure)

结局指标

主要结局

POSAS observer score change will be assessed by POSAS observer scale (The Patient and Observer Scar Assessment Scale v2.0) just prior to second c-section and at 6,12 and 24 weeks following the c-section.

时间窗: just prior to second c-section and at 6,12,24 weeks

POSAS patient score change will be assessed by POSAS patient scale (The Patient and Observer Scar Assessment Scale v2.0) just prior to second c-section and at 6,12 and 24 weeks following the c-section.

时间窗: just prior to second c-section and at 6,12,24 weeks

Vancouver scar score change will be assessed by Vancouver scar scale just prior to second c-section and at 6,12 and 24 weeks following the c-section.

时间窗: just prior to second c-section and at 6,12,24 weeks

次要结局

未报告次要终点

研究者

发起方
Suleymaniye Birth And Women's Health Education And Research Hospital
申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验